Technical Analysis for GNMK - GenMark Diagnostics, Inc.

Grade Last Price % Change Price Change
grade F 4.95 -0.20% -0.01
GNMK closed down 0.2 percent on Friday, January 17, 2020, on 87 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Flat
Historical GNMK trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
NR7 Range Contraction 0.00%
20 DMA Resistance Bearish -0.20%
MACD Bullish Signal Line Cross Bullish -0.20%
MACD Bearish Signal Line Cross Bearish 5.66%
NR7 Range Contraction 5.66%
Inside Day Range Contraction 5.66%
New 52 Week Closing Low Bearish 7.03%
New 52 Week Low Weakness 7.03%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


GenMark Diagnostics, Inc., a molecular diagnostics company, engages in the development, manufacturing, marketing, sale, and support of instruments and molecular tests based on its proprietary eSensor detection technology in the United States. The company's products include XT-8 system, an automated molecular diagnostic system that enables reference laboratories and hospitals to perform molecular diagnostic tests. It also offers 8 diagnostic tests for use with its XT-8 system that includes Cystic Fibrosis Genotyping Test, which detects a panel of mutations associated with cystic fibrosis; Warfarin Sensitivity test that determines an individual's ability to metabolize the oral anticoagulant warfarin; Thrombophilia Risk Test, which detects an individual's increased risk of blood clots; and Respiratory Viral Panel test that simultaneously detects and differentiates 14 clinically relevant viruses from patients with influenza-like illnesses. The company's diagnostic tests also include Hepatitis C Virus Genotyping test for the detection and typing/subtyping of HCV; 3A4/3A5 Genotyping test designed for the detection and genotyping of the alleles of the CYP450 3A4 gene locus and CYP450 3A5 gene locus; and 2C19 Genotyping test for the detection and genotyping alleles of the cytochrome P450 (CYP450) 2C19 gene locus. In addition, the company engages in developing a NexGen system to integrate automated nucleic acid extraction and amplification with its eSensor detection technology to enable technicians to place a patient sample into test cartridge and obtain results without any additional steps. Genmark Diagnostics, Inc. is headquartered in Carlsbad, California.
Biotechnology Manufacturing Biology Genetics Medical Genetics Diagnostic Tests Medical Tests Cystic Fibrosis Molecular Diagnostics Genotyping HCV Blood Clots Innogenetics

Is GNMK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 8.37
52 Week Low 4.47
Average Volume 307,529
200-Day Moving Average 6.17
50-Day Moving Average 5.29
20-Day Moving Average 4.94
10-Day Moving Average 4.96
Average True Range 0.24
ADX 22.14
+DI 24.76
-DI 28.07
Chandelier Exit (Long, 3 ATRs ) 4.78
Chandelier Exit (Short, 3 ATRs ) 5.18
Upper Bollinger Band 5.36
Lower Bollinger Band 4.52
Percent B (%b) 0.51
BandWidth 16.85
MACD Line -0.12
MACD Signal Line -0.14
MACD Histogram 0.0138
Fundamentals Value
Market Cap 270.6 Million
Num Shares 54.7 Million
EPS -1.22
Price-to-Earnings (P/E) Ratio -4.06
Price-to-Sales 8.35
Price-to-Book 4.53
PEG Ratio 0.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.24
Resistance 3 (R3) 5.25 5.16 5.19
Resistance 2 (R2) 5.16 5.09 5.16 5.17
Resistance 1 (R1) 5.06 5.05 5.02 5.05 5.16
Pivot Point 4.97 4.97 4.95 4.97 4.97
Support 1 (S1) 4.87 4.90 4.83 4.86 4.74
Support 2 (S2) 4.78 4.86 4.78 4.73
Support 3 (S3) 4.68 4.78 4.71
Support 4 (S4) 4.67